StockDuty ← Dashboard Nov 05, 2026 02:31 AM ET
SignalCorporate

Adaptive Biotechnologies raises 2026 MRD revenue guide to $276M-$286M as it targets $1,700-$1,800 ASP

Adaptive Biotechnologies raised 2026 MRD revenue guidance to $276M-$286M targeting $1,700-$1,800 ASP.

Adaptive Biotechnologies raised 2026 MRD revenue guidance to $276M-$286M targeting $1,700-$1,800 ASP.
Adaptive Biotechnologies raised 2026 MRD revenue guidance to $276M-$286M targeting $1,700-$1,800 ASP. — impact context not separately stored; see What changed.
Sources